Timing of sodium-glucose cotransporter 2 inhibitor initiation and post-discharge outcomes in acute heart failure with diabetes: A population-based cohort study

被引:1
|
作者
Wu, Che-Yuan [1 ,2 ]
Shah, Baiju R. [3 ,4 ,5 ]
Sharma, Abhinav [6 ,7 ]
Sheng, Yiru [3 ]
Liu, Peter P. [8 ]
Kopp, Alexander [3 ]
Saskin, Refik [3 ]
Edwards, Jodi D. [8 ,9 ,10 ]
Swardfager, Walter [1 ,2 ,11 ]
机构
[1] Univ Toronto, Dept Pharmacol & Toxicol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada
[2] Sunnybrook Res Inst, Dr Sandra Black Ctr Brain Resilience & Recovery, Hurvitz Brain Sci Program, Toronto, ON, Canada
[3] ICES, Toronto, ON, Canada
[4] Sunnybrook Hlth Sci Ctr, Dept Med, Div Endocrinol, Toronto, ON, Canada
[5] Univ Toronto, Dept Med, Toronto, ON, Canada
[6] McGill Univ, Hlth Ctr, Div Cardiol, Montreal, PQ, Canada
[7] McGill Univ, Hlth Ctr, DREAM CV Lab, Montreal, PQ, Canada
[8] Univ Ottawa, Heart Inst, Ottawa, ON, Canada
[9] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada
[10] ICES UOttawa, Ottawa, ON, Canada
[11] KITE Univ Hlth Network Toronto Rehabil Inst, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
Acute heart failure; Diabetes; SGLT2; inhibitor; Pharmacoepidemiology; IMPACT; RISK;
D O I
10.1002/ejhf.3464
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sodium-glucose cotransporter 2 (SGLT2) inhibitors in acute heart failure. image
引用
收藏
页码:307 / 316
页数:10
相关论文
共 50 条
  • [31] Sodium-Glucose Cotransporter 2 Inhibitors in Cardiovascular and Renal Outcomes in Patients With Diabetes but Without Established Cardiovascular Disease: A Nationwide Population-Based Cohort Study
    Chang, Hao-Chih
    Kuo, Tzu-Ting
    Chen, Yun-Yu
    Lin, Yenn-Jiang
    Chang, Hung-Yu
    Hung, Chung-Lieh
    Chung, Fa-Po
    DIABETES CARE, 2022, 45 (09) : E129 - E130
  • [32] Tolerability and safety barriers to sodium-glucose cotransporter 2 inhibitor initiation in heart failure with reduced ejection fraction
    Salah, Husam M.
    Fudim, Marat
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (09) : 1633 - 1635
  • [33] Evaluation of Loop Diuretic Dosing Following Sodium-Glucose Cotransporter 2 Inhibitor Initiation in Patients With Heart Failure
    Trudeau, Brooke M.
    Allen, Larry A.
    Billups, Sarah J.
    Saseen, Joseph J.
    Pearson, Scott M.
    JOURNAL OF PHARMACY PRACTICE, 2023, 36 (06) : 1330 - 1335
  • [34] Diuretic effects of sodium-glucose cotransporter 2 inhibitor in patients with type 2 diabetes mellitus and heart failure
    Takeuchi, Tetsushiro
    Dohi, Kaoru
    Omori, Taku
    Moriwaki, Keishi
    Sato, Yuichi
    Nakamori, Shiro
    Fujimoto, Naoki
    Fujii, Eitaro
    Yamada, Norikazu
    Ito, Masaaki
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 201 : 1 - 3
  • [35] Review on sodium-glucose cotransporter 2 inhibitor (SGLT2i) in diabetes mellitus and heart failure
    Pradhan, Akshyaya
    Vohra, Shweta
    Vishwakarma, Pravesh
    Sethi, Rishi
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2019, 8 (06) : 1855 - 1862
  • [36] Timing and Adherence Matter for Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure
    Yilmaz, Mehmet Birhan
    Celik, Ahmet
    Sahin, Anil
    Colluoglu, Tugce
    Ural, Dilek
    Kanik, Arzu
    Ata, Naim
    Ulgu, Mustafa Mahir
    Birinci, Suayip
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (07):
  • [37] Sodium-glucose cotransporter 2 inhibitors and heart failure: the best timing for the right patient
    Severino, Paolo
    D'Amato, Andrea
    Prosperi, Silvia
    Costi, Bettina
    Angotti, Danilo
    Birtolo, Lucia Ilaria
    Chimenti, Cristina
    Lavalle, Carlo
    Maestrini, Viviana
    Mancone, Massimo
    Fedele, Francesco
    HEART FAILURE REVIEWS, 2023, 28 (03) : 709 - 721
  • [38] Sodium-glucose cotransporter 2 inhibitors and heart failure: the best timing for the right patient
    Paolo Severino
    Andrea D’Amato
    Silvia Prosperi
    Bettina Costi
    Danilo Angotti
    Lucia Ilaria Birtolo
    Cristina Chimenti
    Carlo Lavalle
    Viviana Maestrini
    Massimo Mancone
    Francesco Fedele
    Heart Failure Reviews, 2023, 28 : 709 - 721
  • [39] Acute Effects of Preventing Heart Failure by Sodium-Glucose Cotransporter 2 Inhibitors
    Yanai, Hidekatsu
    CARDIOLOGY RESEARCH, 2021, 12 (05) : 324 - 326
  • [40] Sodium-glucose cotransporter 2 inhibitors vs. sitagliptin in heart failure and type 2 diabetes: an observational cohort study
    Fu, Edouard L.
    Patorno, Elisabetta
    Everett, Brendan M.
    Vaduganathan, Muthiah
    Solomon, Scott D.
    Levin, Raisa
    Schneeweiss, Sebastian
    Desai, Rishi J.
    EUROPEAN HEART JOURNAL, 2023, 44 (24) : 2216 - +